Comparing 10 vendors in ASEAN Infusion Pump Startups across 0 criteria.
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered and Regional Scope
1.3.2 Inclusions and Exclusions
1.3.3 Years Considered
1.4 Currency Considered
1.5 Unit Considered
1.6 Limitations
1.7 Stakeholders
2.1 Introduction
2.2 Market Dynamics
2.2.1 Drivers
2.2.1.1 Rising demand for ambulatory infusion pumps in home care settings
2.2.1.2 Rapid growth in geriatric population and subsequent rise in chronic diseases
2.2.1.3 Increased adoption of enteral feeding pumps due to surge in pre-term births
2.2.1.4 Growing number of surgical procedures performed worldwide
2.2.1.5 Increased safety & cybersecurity requirements
2.2.2 Restraints
2.2.2.1 Product recalls
2.2.2.2 Stringent regulatory requirements for new product approvals
2.2.2.3 Increasing adoption of refurbished & rental infusion pumps
2.2.3 Opportunities
2.2.3.1 High growth of emerging economies
2.2.3.2 Growing popularity of specialty infusion systems
2.2.4 Challenges
2.2.4.1 Increasing incidence of medication errors and inadequate wireless connectivity in most hospitals
2.3 Trends/Disruptions Impacting Customer Business
2.4 Value Chain Analysis
2.5 Ecosystem Analysis
2.6 Investment and Funding Scenario
2.7 Technology Analysis
2.7.1 Key Technologies
2.7.2 Complementary Technologies
2.7.3 Adjacent Technologies
2.8 Patent Analysis
2.9 Trade Analysis
2.10 Porter’s Five Forces Analysis
2.10.1 Threat of New Entrants
2.10.2 Threat of Substitutes
2.10.3 Bargaining Power of Suppliers
2.10.4 Bargaining Power of Buyers
2.10.5 Intensity of Competitive Rivalry
3.1 Introduction
3.2 Key Player Strategies/Right to Win
3.3 Revenue Analysis
3.4 Market Share Analysis
3.5 Company Valuation and Financial Metrics
3.6 Brand/Product Comparison
3.7 Company Evaluation Matrix: Startups/SMEs
3.7.1 Progressive Companies
3.7.2 Responsive Companies
3.7.3 Dynamic Companies
3.7.4 Starting Blocks
3.7.5 Competitive Benchmarking: Startups/SMEs
3.7.5.1 Detailed list of key startups/SMEs
3.7.5.2 Competitive benchmarking of key startups/SMEs
3.8 Competitive Scenario
3.8.1 Product Launches and Approvals
3.8.2 Deals
3.8.3 Expansions
3.8.4 Others Devolpments
4.1 Allied Medical Limited
4.1.1 Business overview
4.1.2 Products/Solutions/Services offered
4.1.3 Recent developments
4.2 Bionet Co., Ltd.
4.2.1 Business overview
4.2.2 Products/Solutions/Services offered
4.2.3 Recent developments
4.3 Shenzhen Medrena Biotech Co., Ltd
4.3.1 Business overview
4.3.2 Products/Solutions/Services offered
4.3.3 Recent developments
4.4 Tandem Diabetes Care
4.4.1 Business overview
4.4.2 Products/Solutions/Services offered
4.4.3 Recent developments
4.5 Mindray Medical International Limited
4.5.1 Business overview
4.5.2 Products/Solutions/Services offered
4.5.3 Recent developments
4.6 BPL Medical Technologies
4.6.1 Business overview
4.6.2 Products/Solutions/Services offered
4.6.3 Recent developments
4.7 Nareena Lifesciences Private Limited
4.7.1 Business overview
4.7.2 Products/Solutions/Services offered
4.7.3 Recent developments
4.8 Epic Medical
4.8.1 Business overview
4.8.2 Products/Solutions/Services offered
4.8.3 Recent developments
4.9 SOOIL Development Co., Ltd.
4.9.1 Business overview
4.9.2 Products/Solutions/Services offered
4.9.3 Recent developments
4.10 Harvard Bioscience Inc.
4.10.1 Business overview
4.10.2 Products/Solutions/Services offered
4.10.3 Recent developments